PUBLISHER: TechNavio | PRODUCT CODE: 2030577
PUBLISHER: TechNavio | PRODUCT CODE: 2030577
Global Orthobiologics Market 2026-2030
The global orthobiologics market is forecasted to grow by USD 3345.2 mn during 2025-2030, accelerating at a CAGR of 8.1% during the forecast period. The report on the global orthobiologics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of musculoskeletal disorders and geriatric demographic shifts, technological advancements in bioactive materials and tissue engineering, increased incidence of sports-related injuries and demand for rapid recovery.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 7.6% |
| CAGR | 8.1% |
| Incremental Value | $3345.2 mn |
Technavio's global orthobiologics market is segmented as below:
By Application
- Spinal fusion
- Reconstructive surgery
- Trauma repair
- Others
By Product
- Bone graft substitutes
- Viscosupplementation
- Stem cells
By End-User
- Hospitals
- ASCs
- Orthopedic clinics
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the strategic transition toward advanced bioactive allografts and synthetic integration as one of the prime reasons driving the global orthobiologics market growth during the next few years. Also, expansion of minimally invasive delivery systems and procedural efficiency and consolidation and ecosystem expansion through strategic acquisitions will lead to sizable demand in the market.
The report on the global orthobiologics market covers the following areas:
- Global orthobiologics market sizing
- Global orthobiologics market forecast
- Global orthobiologics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global orthobiologics market vendors that include AlloSource, Alphatec Holdings Inc., Anika Therapeutics Inc., Arthrex Inc., Bioventus LLC, BoneSupport Holding AB, Globus Medical Inc., Integra LifeSciences Corp., Johnson and Johnson Services, Kuros Biosciences AG, LifeNet Health Inc., Medtronic Plc, MTF Biologics, Orthofix Medical Inc., RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., Xtant Medical Holdings Inc., Zimmer Biomet Holdings Inc.. Also, the global orthobiologics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Orthobiologics Market 2020 - 2024
- Historic Market Size - Data Table on Global Orthobiologics Market 2020 - 2024 ($ million)
- 5.2 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.3 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- 5.4 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Orthobiologics Market
- 6.2 Impact of Geopolitical Conflict on Global Orthobiologics Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Application
- 8.1 Market segments
- 8.2 Comparison by Application
- 8.3 Spinal fusion - Market size and forecast 2025-2030
- 8.4 Reconstructive surgery - Market size and forecast 2025-2030
- 8.5 Trauma repair - Market size and forecast 2025-2030
- 8.6 Others - Market size and forecast 2025-2030
- 8.7 Market opportunity by Application
- Market opportunity by Application ($ million)
9 Market Segmentation by Product
- 9.1 Market segments
- 9.2 Comparison by Product
- 9.3 Bone graft substitutes - Market size and forecast 2025-2030
- 9.4 Viscosupplementation - Market size and forecast 2025-2030
- 9.5 Stem cells - Market size and forecast 2025-2030
- 9.6 Market opportunity by Product
- Market opportunity by Product ($ million)
10 Market Segmentation by End-user
- 10.1 Market segments
- 10.2 Comparison by End-user
- 10.3 Hospitals - Market size and forecast 2025-2030
- 10.4 ASCs - Market size and forecast 2025-2030
- 10.5 Orthopedic clinics - Market size and forecast 2025-2030
- 10.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 Sweden - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Thailand - Market size and forecast 2025-2030
- 12.5.6 Indonesia - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 South Africa - Market size and forecast 2025-2030
- 12.6.4 Israel - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Egypt - Market size and forecast 2025-2030
- 12.6.7 UAE - Market size and forecast 2025-2030
- 12.6.8 Colombia - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising prevalence of musculoskeletal disorders and geriatric demographic shifts
- Technological advancements in bioactive materials and tissue engineering
- Increased incidence of sports-related injuries and demand for rapid recovery
- 13.2 Market challenges
- Stringent regulatory pathways and standardization hurdles
- Complex reimbursement landscapes and payer fragmentation
- High research costs and clinical limitations of advanced biologics
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Strategic transition toward advanced bioactive allografts and synthetic integration
- Expansion of minimally invasive delivery systems and procedural efficiency
- Consolidation and ecosystem expansion through strategic acquisitions
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 AlloSource
- AlloSource - Overview
- AlloSource - Product / Service
- AlloSource - Key offerings
- SWOT
- 15.5 Anika Therapeutics Inc.
- Anika Therapeutics Inc. - Overview
- Anika Therapeutics Inc. - Product / Service
- Anika Therapeutics Inc. - Key offerings
- SWOT
- 15.6 Bioventus LLC
- Bioventus LLC - Overview
- Bioventus LLC - Business segments
- Bioventus LLC - Key offerings
- Bioventus LLC - Segment focus
- SWOT
- 15.7 Globus Medical Inc.
- Globus Medical Inc. - Overview
- Globus Medical Inc. - Product / Service
- Globus Medical Inc. - Key offerings
- SWOT
- 15.8 Integra LifeSciences Corp.
- Integra LifeSciences Corp. - Overview
- Integra LifeSciences Corp. - Business segments
- Integra LifeSciences Corp. - Key offerings
- Integra LifeSciences Corp. - Segment focus
- SWOT
- 15.9 Johnson and Johnson Services
- Johnson and Johnson Services - Overview
- Johnson and Johnson Services - Business segments
- Johnson and Johnson Services - Key news
- Johnson and Johnson Services - Key offerings
- Johnson and Johnson Services - Segment focus
- SWOT
- 15.10 Kuros Biosciences AG
- Kuros Biosciences AG - Overview
- Kuros Biosciences AG - Business segments
- Kuros Biosciences AG - Key offerings
- Kuros Biosciences AG - Segment focus
- SWOT
- 15.11 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- 15.12 MTF Biologics
- MTF Biologics - Overview
- MTF Biologics - Product / Service
- MTF Biologics - Key offerings
- SWOT
- 15.13 Orthofix Medical Inc.
- Orthofix Medical Inc. - Overview
- Orthofix Medical Inc. - Business segments
- Orthofix Medical Inc. - Key news
- Orthofix Medical Inc. - Key offerings
- Orthofix Medical Inc. - Segment focus
- SWOT
- 15.14 RTI Surgical Inc.
- RTI Surgical Inc. - Overview
- RTI Surgical Inc. - Product / Service
- RTI Surgical Inc. - Key offerings
- SWOT
- 15.15 Smith and Nephew plc
- Smith and Nephew plc - Overview
- Smith and Nephew plc - Business segments
- Smith and Nephew plc - Key offerings
- Smith and Nephew plc - Segment focus
- SWOT
- 15.16 Stryker Corp.
- Stryker Corp. - Overview
- Stryker Corp. - Business segments
- Stryker Corp. - Key offerings
- Stryker Corp. - Segment focus
- SWOT
- 15.17 Xtant Medical Holdings Inc.
- Xtant Medical Holdings Inc. - Overview
- Xtant Medical Holdings Inc. - Product / Service
- Xtant Medical Holdings Inc. - Key offerings
- SWOT
- 15.18 Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. - Overview
- Zimmer Biomet Holdings Inc. - Business segments
- Zimmer Biomet Holdings Inc. - Key news
- Zimmer Biomet Holdings Inc. - Key offerings
- Zimmer Biomet Holdings Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
